Results 131 to 140 of about 1,171,567 (281)

Recent Non‐Suicidal Self‐Injury in Autistic Adolescents and Adults: Characteristics, Clinical Correlates and Suicidal Thoughts and Behaviors

open access: yesAutism Research, EarlyView.
ABSTRACT Non‐suicidal self‐injury (NSSI) is prevalent among autistic adolescents and adults, yet research on its clinical characteristics, functions, and association with suicidal thoughts and behaviors (STBs) in this population remains limited. This study compared these domains between autistic adolescents and adults with and without recent NSSI.
Safaa Eldeeb   +7 more
wiley   +1 more source

Experiences with remote ethics consultation: a qualitative study with ethics consultants in Germany

open access: yesBMC Medical Ethics
Abstract Background The use of remote methods such as video conferencing has the potential to improve access to ethics consultations, particularly in outpatient and rural healthcare settings. Although their use has increased since the COVID-19 pandemic, little is known about ethics consultants’
Braun, Esther   +4 more
openaire   +2 more sources

Pharmacy Guidelines PHC Remote

open access: yes, 2018
The Pharmacy Guidelines section includes:;Section 250 NT Medicines, Poisons and Therapeutic Goods Act PHC Remote Guideline;Cold Chain PHC Remote Guideline; Disposal of Unwanted Medicines Following an Emergency / Disaster Event PHC Remote Guideline;Dose ...

core  

Nonadherence and uncontrolled arterial hypertension in Croatia—Insights from the May Measurement Month 2023 campaign and Hunting the silent killer programme

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims To determine the prevalence of non‐adherence to antihypertensive medicines and to identify demographic and behavioral factors associated with non‐adherence in subjects enrolled in the May Measurement Month (MMM) 2023, as part of the permanent public health action Hunting the silent killer.
Valerija Bralić Lang   +12 more
wiley   +1 more source

Psoriasis healthcare during the COVID-19 pandemic: a survey among psoriasis patients (PsoCovidCare)

open access: yesJournal of Dermatological Treatment
Background During the COVID-19 pandemic, psoriasis care underwent significant changes in consultation methods and treatment management. However, comprehensive data on these changes and patient perceptions are limited.Aims To evaluate the pandemic’s ...
C. D. Wortman   +7 more
doaj   +1 more source

Antimicrobial Use Among Patients Receiving Palliative Care Consultation

open access: yes, 2010
We sought to characterize antimicrobial use among patients receiving palliative care ...
Malani, Preeti N   +4 more
core   +1 more source

Evaluating a virtual paediatric adverse drug reaction clinic

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Adverse drug reactions (ADRs) are a common problem in paediatric health care. There is limited access to expertise in the evaluation and management of potential ADRs in children, limiting access to these services and creating delays in assessment and management.
Emily Hauck   +2 more
wiley   +1 more source

Mobile health interventions to improve adherence to oral anticoagulant treatment: A systematic review and critical analysis

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Non‐adherence to oral anticoagulants (OACs) is associated with significant morbidity and mortality. Mobile health (mHealth) interventions have been used to improve medication adherence across the three phases of initiation, implementation and persistence.
Non Davies   +2 more
wiley   +1 more source

Substantial improvement of histopathological diagnosis by whole-slide image-based remote consultation. [PDF]

open access: yesVirchows Arch, 2022
Shinohara S   +29 more
europepmc   +1 more source

Comparing outcomes using low‐dose apixaban and anti‐Xa monitoring and vitamin K antagonists in patients with renal replacement therapy

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Background Guidelines recommend oral anticoagulation for stroke prevention in atrial fibrillation and secondary prevention of venous thromboembolism. Outside the United States, apixaban is unlicensed for use in patients with end‐stage renal disease (ESRD) receiving renal replacement therapy (RRT).
John K. Bartoli‐Abdou   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy